Science and Technology Science and Technology
Tue, December 16, 2008
Mon, December 15, 2008
[ Mon, Dec 15th 2008 ] - Market Wire
FDA Approves Genzyme s Mozobil

IRIS International to Host One-on-One Meetings with Financial Analysts and Fund Managers in San Francisco, January 14, 2009


Published on 2008-12-15 07:06:11 - Market Wire
  Print publication without navigation


CHATSWORTH, Calif.--([ BUSINESS WIRE ])--IRIS INTERNATIONAL, INC. (NASDAQ: IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, announced today that management will host a series of one-on-one meetings with analysts and fund managers on Wednesday, January 14, 2009, to be held at the Hilton San Francisco,333 O'Farrell Street, San Francisco, Ca. The full day of meetings is being organized alongside the 27th Annual JP Morgan Healthcare Conference in San Francisco.

"The J.P. Morgan Annual Healthcare Conference brings together thousands of analysts, fund managers and institutions to the San Francisco Bay area and, while IRIS is not a presenting company, we believe this forum offers an excellent opportunity for IRIS to introduce the Company and provide an update to institutional investors who are planning to be in San Francisco during the conference," stated Cesar Garcia, IRIS Chairman, President and Chief Executive Officer.

Meetings with IRIS management at the Hilton San Francisco on January 14 are by invitation only. Those interested in scheduling a one-on-one, are asked to contact Ron Stabiner with The Wall Street Group at (212) 888-4848 or email, [ rstabiner@thewallstreetgroup.com ]. The Hilton SF is conveniently located in Union Square and is a few short blocks from the Westin St. Francis, the conference host hotel.

About IRIS International

IRIS International is a leading global in vitro diagnostics company focused on products that analyze particles and living cell forms and structures, or morphology of a variety of body fluids. The Company's products leverage its strengths in flow imaging technology, particle recognition and automation to bring efficiency to hospital and commercial laboratories. The initial applications for its technology have been in the urinalysis market and the Company is the leading worldwide provider of urine microscopy systems, with more than 2,000 systems sold in over 50 countries.